Pleural mesothelioma is a rare and aggressive cancer. The cancer with a poor prognosis is mainly caused by asbestos. Surgery is an important part of treating pleural mesothelioma, but the impact of surgery on patients’ survival is unclear and sparking debate. A recent study was presented at the World Conference[…]
From the blog
Opdivo and Yervoy Before and After Surgery and a New Blood Test are Improving Mesothelioma Treatment
Researchers are reporting promising results for people with mesothelioma who can have surgery. One researcher tested immunotherapy before and after surgery while the other researcher studied a blood test that helps doctors detect mesothelioma earlier than scans. Doctors at several cancer centers, including Johns Hopkins, ran an early clinical trial[…]
Cell Mutations and Peritoneal Mesothelioma
Peritoneal mesothelioma is a hard cancer to treat because it is very aggressive and rare. It is usually found late due to it being rare and having unclear symptoms, making treatment very difficult. Current treatments that can include surgery and chemotherapy have limited success against the cancer. New ways to[…]
New Biomarkers for Diagnosing Mesothelioma
Mesothelioma is a rare cancer linked to asbestos exposure that is dangerous for elderly Americans. It is hard to tell the difference between reactive and cancerous cells. This could be changed though due to a study in the American Journal of Pathology. The study identifies a key biomarker, ACADL, using[…]
Palliative Care for Mesothelioma Symptoms
Palliative care is crucial in improving quality of life for people with life threatening diseases like mesothelioma. Understanding the spectrum of diseases that patients experience is important for providing effective care. Palliative care is a medical specialty that focuses on easing pain and other life limiting symptoms. Palliative care is[…]
Mesothelioma Diagnosis
Mesothelioma is a rare and hard to diagnose cancer. There are many challenges patients and caregivers must face once someone is diagnosed with mesothelioma. There are expert guidelines that were recently updated by the International Mesothelioma Interest group. The group provides insights into mesothelioma’s diagnosis, which is incredibly valuable for[…]
Empyema Challenges After Pleural Mesothelioma Surgery
Pleural mesothelioma, a cancer linked to asbestos exposure, is very tough to treat. Surgery is one part of multimodal therapy that aims to remove as much cancer as possible. Surgery is a very useful tool in the treatment of mesothelioma, but after surgery, complications can occur. One complication can be[…]
Advances in Immunotherapy for Mesothelioma
Malignant mesothelioma is a very rare cancer that often has a poor outlook in cancer treatment. Immunotherapy, especially in the form of immune checkpoint inhibitors, has brought hope. It shows the potential for better outcomes in mesothelioma patients. A new article in Open Respiratory Archives provides a history of recent[…]
Carcinogenicity of Forsterite Compared to Asbestos
Mesothelioma, a rare cancer caused by asbestos, continues to be a global health issue. The most common form of asbestos is chrysotile. Recent research looked at chrysotile and a heat-treated form called forsterite. This research can help with safer asbestos disposal in the future. A recent study examined whether forsterite,[…]
New Clinical Trial is Testing CAR-T Cell Therapy for Mesothelioma and Other Hard to Treat Tumors
A new clinical trial that launched this month is testing a new immunotherapy regimen that could offer hope to people with mesothelioma and other hard to treat cancers. It will be examining an experimental treatment that utilizes CAR-T cells, an immune cell engineered to find and attack cancer cells. The[…]
Skip to content